Article Information
- Received June 29, 1999
- Revision received August 5, 1999
- Accepted August 6, 1999
- First published October 15, 1999.
- Version of record published October 15, 1999.
Author Information
Author contributions
Disclosures
- Received June 29, 1999.
- Revision received August 5, 1999.
- Accepted August 6, 1999.
We thank Drs. Makoto Ishibashi, Ryoichiro Kageyama, Qiufu Ma, Chuck Stiles, David Fischer, Yann Echelard, Rob Wechsler-Reya, and Matt Scott for comments and stimulating discussions; Yann Echelard for preparation of the Wnt-1-GAL4 transgene; and Dong-In Yuk, Bianca Klumpar, and Wendy Liu for technical assistance. D.H.R. was supported by a Physician Postdoctoral Fellowship from the Howard Hughes Medical Institute and Grant HD01182 from National Institutes of Health. B.S.J. was supported by a postdoctoral fellowship of the Medical Research Council of Canada. These studies were funded by National Institutes of Health Grants NS32691 and HD30249 (A.P.M.) and the Charles H. Hood Foundation and Brain Tumor Society (D.H.R.). D.H.R. is a recipient of a Basil O’Conor Starter Scholar Award from the March of Dimes Foundation.
Correspondence should be addressed to Dr. David H. Rowitch at his present address: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, or to Dr. Andy McMahon, Department of Molecular and Cellular Biology, Harvard University, The Biolabs, 16 Divinity Avenue, Cambridge, MA 02138.
Dr. St.-Jacques’s present address: Ontogeny, Inc., Cambridge, MA 02138.
Online Impact